This is a guest post from Susan K Finston, President of Finston Consulting. This is the latest entry in an occasional series tracking the microbiome. I first wrote about the potential of the microbiome for human health in October 2015. At that time there was little awareness of the significance and potential of the human microbiome. […]
This article was originally published by James A Smith, Zeeshaan Arshad, Hannah Thomas, Andrew J Carr & David A Brindley in Nature Biotechnology v35, pp 210–214 (2017) under a creative…
The post Evidence of insufficient quality of reporting in patent l…
This paper was originally published by Bhaven N. Sampat and Kenneth C. Shadlen in PLoS ONE 13(4): e0194714 under a Creative Commons license. Abstract India, like many developing countries, only recently…
The post Indian pharmaceutical patent prosecutio…
This paper was originally published by Qiaolei Jiang and Chunjuan Luan in Globalization and Health 2018 14:92 under a Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/). Abstract Background Despite the …
Patents filed since 1995 last for 20 years from the date of patent application filing. This is true for “utility” patents, but the terms for certain other, less common types…
The post How Long Do Drug Patents Last? appeared first on DrugPatentWatch – M…
In response to requests for a simple generic entry opportunity date for drugs we have leveraged our 1-step dominant patent identification method to produce a continuously-updated list of upcoming patent expirations and generic entry opportunity dates. The list is licensed under a Creative Commons Attribution 4.0 International License, which means you are free to republish it, […]
This article was originally published by Basavaraj S, Guru V. Betageri in Acta Pharmaceutica Sinica B Volume 4, Issue 1, February 2014, Pages 3-17 under a Creative Commons License. Abstract Drug discovery and development…
The post Can formulation and d…
This paper was originally published by T. Joseph Mattingly, Joseph F. Levy, Julia F. Slejko, Nneka C. Onwudiwe, and Eleanor M. Perfetto in PharmacoEconomics Volume 36, Issue 9 under a Creative Commons…
The post Estimating Drug Costs: How do Manufacture…
This paper was originally published by Toon van der Gronde, Carin A. Uyl-de Groot, and Toine Pieters in PLoS ONE 12(8): e0182613 under a creative commons license. Abstract Context Recent public outcry…
The post Addressing the challenge of high-priced p…
The theoretical construct of what happens when drug patents expire is simple and appealing (to consumers, anyway). A name brand drug patent expires, generics are waiting in the wings to…
The post What Happens When a Drug Patent Expires? appeared first …